Primary Care Can Effectively Manage Obstructive Sleep Apnea

Share this content:
Primary Care Can Effectively Manage Obstructive Sleep Apnea
Primary Care Can Effectively Manage Obstructive Sleep Apnea

MONDAY, April 30, 2018 (HealthDay News) -- Primary care management of obstructive sleep apnea (OSA) is as effective and more cost-effective than in-laboratory diagnosis, according to a study published online April 17 in the American Journal of Respiratory and Critical Care Medicine.

M. Ángeles Sánchez-Quiroga, M.D., from Virgen del Puerto Hospital in Madrid, and colleagues randomized 303 sequentially screened patients with an intermediate-to-high probability of OSA to primary care management (a portable monitor with automatic scoring and semi-automatic therapeutic decision-making) or in-laboratory management (polysomnography and specialized therapeutic decision-making). All patients received continuous positive airway pressure treatment or sleep hygiene and dietary treatment alone.

The researchers found that the primary care protocol was noninferior to the in-laboratory protocol based on use of the Epworth sleepiness scale. Furthermore, primary health care management was more cost-effective, with a lower cost of €537.8 per patient.

"Primary health care area management may be an alternative to in-laboratory management for patients with an intermediate to high OSA probability," the authors write. "Given the clear economic advantage of outpatient management, this finding could change established clinical practice."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »